Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
Home > How Our Patients Perform > Glioblastoma Multiforme   
How Our Patients Perform : Glioblastoma Multiforme [GBM]
Overall survival rates and a realistic evaluation of how UCLA Neuro-Oncology cares for patients with a Glioblastoma Multiforme
What is a Glioblastoma Multiforme
What is the Average Survival of a Newly Diagnosed GBM Patient treated by UCLA Neuro-Oncology
What are the first steps of treatment for a Glioblastoma Multiforme tumor
What chemotherapy agents does UCLA Neuro-Oncology use to treat patients with a Glioblastoma Multiforme tumor
How much experience does UCLA Neuro-Oncology have treating Glioblastoma Multiforme patients
What are the Advantages of being treated at a University Medical Center
What CLINICAL TRIALS are available for Glioblastoma Multiforme Patients
How do I Refer a Glioblastoma Multiforme Patient to UCLA
 

What are the first steps of treatment of a Glioblastoma Multiforme tumor?

What are the Advantages of being treated at a University Medical Center.

How do I Refer a Glioblastoma Multiforme Patient to UCLA.

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2016 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2016 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:5/2/2016 4:19:39 AM PST]